Alphabet

Yes, DeepMind crunches the numbers – but is it really a magic bullet? | John Naughton

The machine learning outfit’s foray into pharmaceuticals could be very useful, but its grand claims should be taken with a pinch of salt The most interesting development of the week had nothing to do with Facebook or even Google losing its appeal against a €2.4bn fine from the European commission for abusing its monopoly of …

Yes, DeepMind crunches the numbers – but is it really a magic bullet? | John Naughton Read More »

Alphabet’s DeepMind forms AI drug discovery unit Isomorphic Labs

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into DeepMind’s AI-powered AlphaFold engine that last year became the first to solve the tricky problem of predicting protein folding, but will operate separately. It …

Alphabet’s DeepMind forms AI drug discovery unit Isomorphic Labs Read More »

Strive Health Raises $140M for Value-Based Kidney Care Platform

What You Should Know: – Strive Health, a Denver-based provider of value-based kidney care today announced $140 million in Series B funding with Alphabet’s independent growth fund, CapitalG, as the lead investor. Strive has more than doubled its presence in regional markets and grown its employee base by more than 600% in the last year. This funding will further increase that momentum.  …

Strive Health Raises $140M for Value-Based Kidney Care Platform Read More »

Verily and Janssen Launch COVID-19 Immune Response Study

What You Should Know: – Verily and Janssen launches COVID-19 Immune Response Study that aims to collect detailed information about how the coronavirus affects the immune system immediately after someone tests positive for COVID-19. Verily, an Alphabet company, is partnering with Janssen Research & Development LLC (Janssen) to launch a COVID-19 Immune Response Study as …

Verily and Janssen Launch COVID-19 Immune Response Study Read More »

In adding more conditions, is Onduo becoming a me-too platform of Omada and Livongo?

Verily’s virtual diabetes platform, Onduo, is expanding to support additional conditions and languages, Onduo’s CEO Vindell Washington shared. How will the company differentiate itself among a growing number of multi-condition platforms, such as Livongo and Omada?

Google’s Verily eyes 2021 growth after £700m funding round

Verily is planning “significant and focused growth” in 2021 after closing a $700 million funding round from investors including its parent company, and Google holding firm, Alphabet. The capital injection will support wide-ranging plans for the new year that include several life sciences programmes in surgery, pathology and immunology, which would add to the digital …

Google’s Verily eyes 2021 growth after £700m funding round Read More »

Cityblock Health Reaches $1B Valuation, Raises $160M to Address Systemic Healthcare Inequity

What You Should Know: – Cityblock Health, a transformative, value-based healthcare provider focused on improving healthcare outcomes for marginalized communities, today announced a $160M Series C round, bringing its total raised to $300M. – Cityblock is a care delivery trailblazer working to right the injustices of a healthcare system that cycles vulnerable communities through frequent …

Cityblock Health Reaches $1B Valuation, Raises $160M to Address Systemic Healthcare Inequity Read More »

Verily Forms New Subsidiary Focused on Employer Stop-Loss Through Precision Risk

What You Should Know: – Alphabet’s Verily has established a new subsidiary, Coefficient, with a mission to create value by combining innovative health technology solutions with new insurance and payment models. Verily is the majority shareholder and Swiss Re Corporate Solutions, an established player in the employer stop-loss market, has a minority stake in the …

Verily Forms New Subsidiary Focused on Employer Stop-Loss Through Precision Risk Read More »

Alphabet’s Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing

Shots: Verily has expedite the COVID-19 testing with a new lab-based at South San Francisco. The lab will use the technology from Thermo Fisher Scientific’s‎ TaqPath test kit that has received the US FDA’s EUA to test COVID-19 Verily has submitted a EUA for an adaptation of the TaqPath test to use in testing pooled …

Alphabet’s Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing Read More »